Jury echoes judge in Medtronic/Guidant stent case
This article was originally published in Clinica
A Delaware jury has issued a verdict in Guidant's favour in a lawsuit against Medtronic over patents covering stent technology. The jury found that Medtronic stents, including the cobalt alloy Driver stent that forms the platform for its development-stage drug-eluting device, infringed Guidant's Lau patents. It also ruled that the Lau patents were valid.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.